ICETANA LIMITED — Director's Dealing 2020

Nov 26, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity icetana Limited ABN 90 140 449 725

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Matthew Macfarlane
Date of last notice	7 August 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	A. Direct B. Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/a
Date of change	A. 23 November 2020 to 25 November 2020 B. 27 November 2020

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Direct: 250,000 Ordinary Shares 2,344,348 Options ($0.30, vesting over 3 years from 20 December 2019, expiring 30 November 2023) 5,642,702 Options ($0.25, vesting over 3 years from 7 May 2020, expiring 31 March 2020) – grant subject to shareholder approval 262,500 Class A Performance Rights 262,500 Class B Performance Rights 262,500 Class C Performance Rights 262,500 Class D Performance Rights Indirect: 1,074,649 Ordinary Shares 131,106 Class A Shareholder Options 131,106 Class B Shareholder Options
Class	A. Ordinary Shares B.$0.25 ESIP Options
Number acquired	A. 120,000 B. 5,642,702 Options ($0.25, vesting over 3 years from 7 May 2020, expiring 31 March 2024)
Number disposed	A. Nil B. Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	A. $20,922.76 B. Nil – granted pursuant to ESIP following shareholder approval at 2020 Annual General Meeting
No. of securities held after change	Direct: 370,000 Ordinary Shares 2,344,348 Options ($0.30, vesting over 3 years from 20 December 2019, expiring 30 November 2023) 5,642,702 Options ($0.25, vesting over 3 years from 7 May 2020, expiring 31 March 2024) 262,500 Class A Performance Rights 262,500 Class B Performance Rights 262,500 Class C Performance Rights 262,500 Class D Performance Rights Indirect: 1,074,649 Ordinary Shares 131,106 Class A Shareholder Options 131,106 Class B Shareholder Options

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change A. On-market trade Example: on-market trade, off-market trade, exercise of options, issue B. Granted pursuant to ESIP following of securities under dividend reinvestment plan, participation in buyback shareholder approval at 2020 Annual General Meeting

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/a
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/a
If prior written clearance was provided, on what date was this provided?	N/a

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3